# NLRP3

## Overview
The NLRP3 gene encodes the NLR family pyrin domain containing 3 protein, a crucial component of the innate immune system. This protein is a member of the nucleotide-binding domain and leucine-rich repeat (NLR) family, which plays a pivotal role in the formation and activation of the NLRP3 inflammasome, a multiprotein complex involved in the inflammatory response. The NLRP3 protein is characterized by its pyrin domain (PYD), nucleotide-binding and oligomerization domain (NACHT), and leucine-rich repeat (LRR) domain, which collectively facilitate its function in sensing cellular stress and danger signals (Sharif2019Structural; Sharma2021Structure). Upon activation, the NLRP3 inflammasome triggers the maturation of pro-inflammatory cytokines, such as IL-1β and IL-18, thereby initiating inflammation and immune defense mechanisms (Mangan2018Targeting). Dysregulation or mutations in the NLRP3 gene are linked to various autoinflammatory and autoimmune diseases, highlighting its clinical significance in maintaining immune homeostasis and its potential as a therapeutic target (Wang2020The; Li2020Role).

## Structure
The NLRP3 protein is composed of three main domains: the N-terminal pyrin domain (PYD), the central nucleotide-binding and oligomerization domain (NACHT), and the C-terminal leucine-rich repeat (LRR) domain (Sharma2021Structure). The PYD domain has a six-helix architecture with a central hydrophobic core, similar to other PYDs like NLRP1 and NLRP4, and features a unique disulfide bond between conserved residues C8 and C108, which may play a role in redox signaling (Sharma2021Structure; Bae2011Crystal). 

The NACHT domain includes subdomains such as the nucleotide-binding domain (NBD), helical domain 1 (HD1), winged helix domain (WHD), and a variable HD2 module. This domain is crucial for ATP-induced oligomerization, a key step in inflammasome activation (Ma2023Pharmacological; Sharif2019Structural). The LRR domain, consisting of 12 repeats, is involved in ligand sensing and autoregulation, although it is not essential for inflammasome assembly (Sharif2019Structural; Sharma2021Structure).

Post-translational modifications such as phosphorylation and ubiquitination regulate NLRP3 activity, influencing its interaction with other proteins and its activation state (Sharma2021Structure). The protein can form oligomeric structures, which are essential for its function in the immune response (Ma2023Pharmacological).

## Function
The NLRP3 gene encodes a protein that is a critical component of the NLRP3 inflammasome, a multiprotein complex involved in the innate immune response. In healthy human cells, the NLRP3 inflammasome acts as a sensor for various danger signals, including pathogen-associated molecular patterns (PAMPs), damage-associated molecular patterns (DAMPs), and environmental irritants. These signals can include whole pathogens, bacterial toxins, and cellular stress indicators (Schroder2010The). 

Upon activation, the NLRP3 protein undergoes oligomerization, recruiting the adaptor protein ASC and procaspase-1, leading to the activation of caspase-1. This process results in the cleavage of pro-inflammatory cytokines such as IL-1β and IL-18 into their active forms, which are crucial for initiating inflammation and defending against infections (Mangan2018Targeting). The activation of the NLRP3 inflammasome is tightly regulated and involves mechanisms such as potassium efflux, lysosomal rupture, and reactive oxygen species (ROS) production (Schroder2010The).

In healthy cells, the NLRP3 inflammasome helps maintain immune homeostasis by responding to cellular stress and damage, preventing excessive inflammation. It plays a role in maintaining tissue homeostasis by allowing immune cells to detect and respond to changes in the tissue environment (Mangan2018Targeting).

## Clinical Significance
Mutations in the NLRP3 gene are associated with a group of autoinflammatory diseases known as Cryopyrin-Associated Periodic Syndromes (CAPS). These include Familial Cold Autoinflammatory Syndrome (FCAS), Muckle-Wells Syndrome (MWS), and Neonatal-Onset Multisystem Inflammatory Disease (NOMID), also referred to as Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome (Wang2020The; de2017The). These conditions are characterized by recurrent systemic inflammation, fever, and specific tissue inflammation affecting joints, skin, and eyes, with central nervous system involvement in NOMID/CINCA (Wang2020The).

The NLRP3 inflammasome is also implicated in various chronic inflammatory and autoimmune diseases. It plays a role in metabolic diseases such as atherosclerosis, nonalcoholic fatty liver disease (NAFLD), and gout. In these conditions, NLRP3 activation leads to inflammation and disease progression (Wang2020The). Additionally, dysregulation of the NLRP3 inflammasome is linked to autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis, where it contributes to disturbed inflammatory responses (Li2020Role).

Mutations in NLRP3 can result in either germline or somatic mosaic mutations, with germline mutations often associated with more severe phenotypes (Louvrier2020NLRP3associated). The pathogenic role of IL-1β, a cytokine released due to NLRP3 activation, is supported by the effectiveness of anti-IL-1β therapies in treating these conditions (Wang2020The).

## Interactions
The NLRP3 protein interacts with several molecular partners that are crucial for the activation of the NLRP3 inflammasome. NEK7, a mitotic serine and threonine kinase, is a key interacting partner that facilitates NLRP3 oligomerization and the maturation of IL-1β and IL-18 by bridging adjacent NLRP3 subunits (Paik2021An; Leu2023NLRP3). Thioredoxin-interacting protein (TXNIP) binds to NLRP3 in a redox-dependent manner, playing a critical role in inflammasome activation (Paik2021An). 

Cathepsin B is necessary for the activation of the NLRP3 inflammasome in macrophages, interacting with NLRP3 at the endoplasmic reticulum level. This interaction is crucial for the recruitment and activation of pro-inflammatory caspases like caspase-1, leading to the maturation of cytokines such as IL-1β (Chevriaux2020Cathepsin). 

The ASC protein interacts with the pyrin domain (PYD) of NLRP3, forming oligomeric complexes essential for inflammasome activation. This interaction involves specific residues on helices H1, H2, H4, and H5 of NLRP3 (Oroz2016ASC). 

Other proteins like MARK4, which aids in NLRP3 localization to the microtubule-organizing center, and MAVS, which is involved in NLRP3 activation in response to RNA viruses, also interact with NLRP3 (Paik2021An).


## References


[1. (Mangan2018Targeting) Matthew S. J. Mangan, Edward J. Olhava, William R. Roush, H. Martin Seidel, Gary D. Glick, and Eicke Latz. Targeting the nlrp3 inflammasome in inflammatory diseases. Nature Reviews Drug Discovery, 17(8):588–606, July 2018. URL: http://dx.doi.org/10.1038/nrd.2018.97, doi:10.1038/nrd.2018.97. This article has 1040 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nrd.2018.97)

[2. (Ma2023Pharmacological) Qiang Ma. Pharmacological inhibition of the nlrp3 inflammasome: structure, molecular activation, and inhibitor-nlrp3 interaction. Pharmacological Reviews, 75(3):487–520, January 2023. URL: http://dx.doi.org/10.1124/pharmrev.122.000629, doi:10.1124/pharmrev.122.000629. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pharmrev.122.000629)

[3. (Paik2021An) Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, Chihiro Sasakawa, and Eun-Kyeong Jo. An update on the regulatory mechanisms of nlrp3 inflammasome activation. Cellular &amp; Molecular Immunology, 18(5):1141–1160, April 2021. URL: http://dx.doi.org/10.1038/s41423-021-00670-3, doi:10.1038/s41423-021-00670-3. This article has 372 citations.](https://doi.org/10.1038/s41423-021-00670-3)

[4. (Sharif2019Structural) Humayun Sharif, Li Wang, Wei Li Wang, Venkat Giri Magupalli, Liudmila Andreeva, Qi Qiao, Arthur V. Hauenstein, Zhaolong Wu, Gabriel Núñez, Youdong Mao, and Hao Wu. Structural mechanism for nek7-licensed activation of nlrp3 inflammasome. Nature, 570(7761):338–343, June 2019. URL: http://dx.doi.org/10.1038/s41586-019-1295-z, doi:10.1038/s41586-019-1295-z. This article has 481 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41586-019-1295-z)

[5. (Chevriaux2020Cathepsin) Angélique Chevriaux, Thomas Pilot, Valentin Derangère, Harmonie Simonin, Pierre Martine, Fanny Chalmin, François Ghiringhelli, and Cédric Rébé. Cathepsin b is required for nlrp3 inflammasome activation in macrophages, through nlrp3 interaction. Frontiers in Cell and Developmental Biology, March 2020. URL: http://dx.doi.org/10.3389/fcell.2020.00167, doi:10.3389/fcell.2020.00167. This article has 110 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.00167)

[6. (Bae2011Crystal) Ju Young Bae and Hyun Ho Park. Crystal structure of nalp3 protein pyrin domain (pyd) and its implications in inflammasome assembly. Journal of Biological Chemistry, 286(45):39528–39536, November 2011. URL: http://dx.doi.org/10.1074/jbc.m111.278812, doi:10.1074/jbc.m111.278812. This article has 156 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m111.278812)

[7. (Louvrier2020NLRP3associated) Camille Louvrier, Eman Assrawi, Elma El Khouri, Isabelle Melki, Bruno Copin, Emmanuelle Bourrat, Noémie Lachaume, Bérengère Cador-Rousseau, Philippe Duquesnoy, William Piterboth, Fawaz Awad, Claire Jumeau, Marie Legendre, Gilles Grateau, Sophie Georgin-Lavialle, Sonia A. Karabina, Serge Amselem, and Irina Giurgea. Nlrp3-associated autoinflammatory diseases: phenotypic and molecular characteristics of germline versus somatic mutations. Journal of Allergy and Clinical Immunology, 145(4):1254–1261, April 2020. URL: http://dx.doi.org/10.1016/j.jaci.2019.11.035, doi:10.1016/j.jaci.2019.11.035. This article has 52 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2019.11.035)

[8. (Oroz2016ASC) Javier Oroz, Susana Barrera-Vilarmau, Carlos Alfonso, Germán Rivas, and Eva de Alba. Asc pyrin domain self-associates and binds nlrp3 protein using equivalent binding interfaces. Journal of Biological Chemistry, 291(37):19487–19501, September 2016. URL: http://dx.doi.org/10.1074/jbc.M116.741082, doi:10.1074/jbc.m116.741082. This article has 93 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M116.741082)

[9. (Wang2020The) Li Wang and Arthur V. Hauenstein. The nlrp3 inflammasome: mechanism of action, role in disease and therapies. Molecular Aspects of Medicine, 76:100889, December 2020. URL: http://dx.doi.org/10.1016/j.mam.2020.100889, doi:10.1016/j.mam.2020.100889. This article has 269 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2020.100889)

[10. (Leu2023NLRP3) Sy-Ying Leu, Yi-Ling Tsang, Li-Chun Ho, Ching-Chun Yang, Ai-Ning Shao, Chia-Yu Chang, Hui-Kuan Lin, Pei-Jane Tsai, Junne-Ming Sung, and Yau-Sheng Tsai. Nlrp3 inflammasome activation, metabolic danger signals, and protein binding partners. Journal of Endocrinology, February 2023. URL: http://dx.doi.org/10.1530/joe-22-0184, doi:10.1530/joe-22-0184. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1530/joe-22-0184)

[11. (Sharma2021Structure) Meenakshi Sharma and Eva de Alba. Structure, activation and regulation of nlrp3 and aim2 inflammasomes. International Journal of Molecular Sciences, 22(2):872, January 2021. URL: http://dx.doi.org/10.3390/ijms22020872, doi:10.3390/ijms22020872. This article has 87 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22020872)

[12. (de2017The) Carlos de Torre-Minguela, Pablo Mesa del Castillo, and Pablo Pelegrín. The nlrp3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Frontiers in Immunology, January 2017. URL: http://dx.doi.org/10.3389/fimmu.2017.00043, doi:10.3389/fimmu.2017.00043. This article has 137 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2017.00043)

[13. (Schroder2010The) Kate Schroder, Rongbin Zhou, and Jurg Tschopp. The nlrp3 inflammasome: a sensor for metabolic danger? Science, 327(5963):296–300, January 2010. URL: http://dx.doi.org/10.1126/science.1184003, doi:10.1126/science.1184003. This article has 894 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1184003)

[14. (Li2020Role) Zhe Li, Jialong Guo, and Liqi Bi. Role of the nlrp3 inflammasome in autoimmune diseases. Biomedicine &amp; Pharmacotherapy, 130:110542, October 2020. URL: http://dx.doi.org/10.1016/j.biopha.2020.110542, doi:10.1016/j.biopha.2020.110542. This article has 148 citations.](https://doi.org/10.1016/j.biopha.2020.110542)